China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds

  • Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of 10% to 15% of their body weight, roughly in line with results from a similar drug sold by Novo Nordisk , according to a late-stage study published on Saturday.